by Joel Rothman | Aug 7, 2009 | NutriSupLaw
The FDA has put supplement companies on notice that violators can expect earlier detection and prosecution. Remarks by commissioner Margaret Hamburg on Aug. 6 strongly suggest that the agency has shifted to a policy of less talk and more action. In a speech to the...
by Joel Rothman | Jul 1, 2009 | NutriSupLaw
Following up on a post from June 30, the question of consumer confidence in nutritional supplements arises again. The Times-Herald reports that many supplements have quality problems. No one knows just how many of 40,000 products underdeliver on the goods listed...
by Joel Rothman | Jun 24, 2009 | NutriSupLaw
Manufacturers beware. Your regulatory problems may not be over when you pull a product from the store shelves. Matrixx Initiatives Inc. recalled its Zicam products on June 16 and three days later the Securities & Exchange Commission sent a letter of inquiry. The...
by Joel Rothman | May 27, 2009 | NutriSupLaw
In the days following the FDA warning on the dangers of taking Hydroxycut and the manufacturer’s recall, the reaction has been more sliced than divided. There were the oft-seen reactions: NaturalNews headlined its commentary, “FDA Floats Hydroxycut Scare...
by Joel Rothman | May 6, 2009 | NutriSupLaw
The Food & Drug Administration issued on May 1 a consumer warning to stop using Hydroxycut, the heavily marketed weight-loss product. The agency said that “some Hydroxycut products are associated with a number of serious liver injuries” and announced...
